Search Results - "Szukalski, Łukasz"

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial by Dytfeld, Dominik, Wróbel, Tomasz, Jamroziak, Krzysztof, Kubicki, Tadeusz, Robak, Paweł, Walter-Croneck, Adam, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Rybka, Justyna, Majcherek, Maciej, Usnarska-Zubkiewicz, Lidia, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan Maciej, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Lahoud, Oscar B, Zonder, Jeffrey A, Griffith, Kent, Stefka, Andrew, Major, Ajay, Derman, Benjamin A, Jakubowiak, Andrzej J

“…Lenalidomide is a cornerstone of maintenance therapy in patients with newly diagnosed multiple myeloma after autologous stem-cell transplantation. We aimed to…”
Get full text

Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit? by Kalicińska, Elżbieta, Kuszczak, Bartłomiej, Dębski, Jakub, Szukalski, Łukasz, Wątek, Marzena, Strzała, Judyta, Rybka, Justyna, Czyż, Jarosław, Lech-Marańda, Ewa, Zaucha, Jan, Wróbel, Tomasz

“…Introduction Patients with hematological malignancies (HM) require intensive chemotherapy with curative intent, especially in case of AML that results in more…”
Get full text

Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial by Kubicki, Tadeusz, Dytfeld, Dominik, Wróbel, Tomasz, Jamroziak, Krzysztof, Robak, Paweł, Czyż, Jarosław, Tyczyńska, Agata, Druzd‐Sitek, Agnieszka, Giannopoulos, Krzysztof, Szczepaniak, Tomasz, Łojko‐Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Rybka, Justyna, Majcherek, Maciej, Usnarska‐Zubkiewicz, Lidia, Szukalski, Łukasz, Zaucha, Jan Maciej, Mikulski, Damian, Czabak, Olga, Lahoud, Oscar B., Stefka, Andrew, Derman, Benjamin A., Jakubowiak, Andrzej J.

“…Summary Previous studies suggest that postautologous stem cell transplant (ASCT) recovery of polyclonal immunoglobulin from immunoparesis in patients with…”
Get full text

Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real‐life study by Stuckey, Ruth, Ianotto, Jean‐Christophe, Santoro, Marco, Czyż, Anna, Perez Encinas, Manuel M., Gómez‐Casares, María Teresa, Noya Pereira, Maria Soledad, Nałęcz, Anna Kulikowska, Gołos, Aleksandra, Lewandowski, Krzysztof, Szukalski, Łukasz, González‐Martín, Jesús M., Wróbel, Tomasz, Sobas, Marta Anna

“…Summary Thrombosis and haemorrhage are frequent in patients with essential thrombocythaemia (ET). The 2016 revised International Prognostic Score for…”
Get full text

Prediction of major bleeding events in 1381 patients with essential thrombocythemia by Stuckey, Ruth, Ianotto, Jean-Christophe, Santoro, Marco, Czyż, Anna, Encinas, Manuel M. Perez, Gómez-Casares, María Teresa, Pereira, Maria Soledad Noya, de Nałęcz, Anna Kulikowska, Gołos, Aleksandra, Lewandowski, Krzysztof, Szukalski, Łukasz, González-Martín, Jesús M., Sobas, Marta Anna

“…The goal of therapy in essential thrombocythemia (ET) is reducing thrombotic risk. No algorithm to predict hemorrhage risk exists. The impact ofanti-platelet,…”
Get full text

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes by Skalska-Bugala, Aleksandra, Starczak, Marta, Szukalski, Łukasz, Gawronski, Maciej, Siomek-Gorecka, Agnieszka, Szpotan, Justyna, Labejszo, Anna, Zarakowska, Ewelina, Szpila, Anna, Jachalska, Anna, Szukalska, Adriana, Kruszewski, Marcin, Sadowska, Anna, Wasilow, Aleksandra, Baginska, Patrycja, Czyz, Jaroslaw, Olinski, Ryszard, Rozalski, Rafal, Gackowski, Daniel

“…Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are characterized by genomic instability, which may arise from the global hypomethylation of…”
Get full text

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma by Goldman‐Mazur, Sarah, Jurczyszyn, Artur, Castillo, Jorge J., Waszczuk‐Gajda, Anna, Grząśko, Norbert, Radocha, Jakub, Bittrich, Max, Kortüm, K. Martin, Gozzetti, Alessandro, Usnarska‐Zubkiewicz, Lidia, Davila Valls, Julio, Jayabalan, David S., Niesvizky, Ruben, Kelman, Julia, Coriu, Daniel, Rosiñol, Laura, Szukalski, Łukasz, González‐Calle, Veronica, Mateos, Maria V., Jamroziak, Krzysztof, Hus, Iwona, Avivi, Irit, Cohen, Yael, Suska, Anna, Chappell, Aimee, Madduri, Deepu, Chhabra, Saurabh, Kleman, Ariel, Hari, Parameswaran, Delforge, Michel, Robak, Paweł, Gentile, Massimo, Kozłowska, Izabela, Goldberg, Stuart L., Czepiel, Jacek, Silbermann, Rebecca, Olszewski, Adam J., Barth, Peter, Mikala, Gabor, Chim, Chor S., Długosz‐Danecka, Monika, Grosicki, Sebastian, Vesole, David H.

“…The t(14;16) translocation, found in 3%‐5% of newly diagnosed (ND) multiple myeloma (MM), has been associated with adverse outcomes. However, the studies…”
Get full text

Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience by Czyż, Jarosław, Szukalski, Łukasz, Szukalska, Adriana, Budziszewska, Bożena Katarzyna, Lech-Marańda, Ewa, Zdziarska, Joanna, Sacha, Tomasz

“…Eculizumab is an antibody targeting the C5 complement protein. Clinical trials suggest that eculizumab significantly reduces transfusion requirements and…”
Get full text

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia by Puła, Bartosz, Pruszczyk, Katarzyna, Pietrusza, Ewa, Morawska, Marta, Piszczek, Weronika, Kalicińska, Elżbieta, Szeremet, Agnieszka, Tryc-Szponder, Jagoda, Wąsik-Szczepanek, Ewa, Drozd-Sokołowska, Joanna, Krzemień, Helena, Rejus, Aleksandra, Gajewska, Małgorzata, Wiśniewski, Kamil, Wysocki, Maciej, Majeranowski, Alan, Paszkiewicz-Kozik, Ewa, Steckiewicz, Paweł, Szukalski, Łukasz, Bołkun, Łukasz, Długosz-Danecka, Monika, Giannopoulos, Krzysztof, Jamroziak, Krzysztof, Lech-Marańda, Ewa, Hus, Iwona

“…The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has become the cause of a worldwide pandemic, and its clinical infection course in patients with…”
Get full text

Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone by Kubicki, Tadeusz, Jamroziak, Krzysztof, Robak, Paweł, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Wróbel, Tomasz, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan M, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Kruk-Kwapisz, Dorota, Derman, Benjamin A, Major, Ajay, Jakubowiak, Andrzej J, Dytfeld, Dominik

Get more information

Endothelial Activation and Stress Index (EASIX) as an Early Predictor for Mortality and Overall Survival in Hematological and Non-Hematological Patients with COVID-19: Multicenter Cohort Study by Kalicińska, Elżbieta, Biernat, Monika, Rybka, Justyna, Zińczuk, Aleksander, Janocha-Litwin, Justyna, Rosiek-Biegus, Marta, Morawska, Marta, Waszczuk-Gajda, Anna, Drozd-Sokołowska, Joanna, Szukalski, Łukasz, Rymko, Marcin, Jabłonowska, Paula, Simon, Krzysztof, Wróbel, Tomasz

“…COVID-19, as a disease involving the endothelium of multiple organs, is characterized by high mortality rates among hospitalized patients. Patients with…”
Get full text

Cutaneous manifestation of chronic lymphocytic leukemia: a case report and a literature review by Szukalski, Łukasz, Sysakiewicz-Buda, Martyna, Mêciñska-Jundziłł, Kaja, Białecka, Agnieszka, Czyż, Jarosław, Czajkowski, Rafał

Get full text

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients by Goldman-Mazur, Sarah, Jurczyszyn, Artur, Castillo, Jorge J., Waszczuk-Gajda, Anna, Grząśko, Norbert, Radocha, Jakub, Bittrich, Max, Kortüm, Klaus Martin, Gozzetti, Alessandro, Usnarska-Zubkiewicz, Lidia, Valls, Julio D., Jayabalan, David S., Niesvizky, Ruben, Kelman, Julia, Coriu, Daniel, Rosiñol, Laura, Szukalski, Łukasz, González-Calle, Veronica, Mateos, María-Victoria, Jamroziak, Krzysztof, Hus, Iwona, Avivi, Irit, Cohen, Yael, Mazur, Piotr, Suska, Anna, Chappell, Aimee, Madduri, Deepu, Chhabra, Saurabh, Kleman, Ariel, Hari, Parameswaran, Delforge, Michel, Robak, Paweł, Gentile, Massimo, Kozłowska, Izabela, Goldberg, Stuart L., Czepiel, Jacek, Długosz-Danecka, Monika, Silbermann, Rebecca, Olszewski, Adam J., Barth, Peter, Mikala, Gabor, Chim, Chor S., Vesole, David H.

“…The MAF translocations, t(14;16) and t(14;20), are considered as adverse prognostic factors based on few studies with small sample sizes. We report on their…”
Get full text

Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors by Puła, Bartosz, Długosz-Danecka, Monika, Salomon-Perzyński, Aleksander, Szymczyk, Agnieszka, Subocz, Edyta, Budziszewska, Bożena Katarzyna, Rybka, Justyna, Gil, Lidia, Waszczuk-Gajda, Anna, Iskierka-Jażdżewska, Elżbieta, Zaucha, Jan M., Osowiecki, Michał, Piszczek, Weronika, Steckiewicz, Paweł, Szukalski, Łukasz, Hus, Marek, Lech-Marańda, Ewa, Jurczak, Wojciech, Jamroziak, Krzysztof

“…High-dose methylprednisolone (HDMP) with or without anti-CD20 antibody treatment in the pre B-cell receptor inhibitor (BCRi) era was used as potential salvage…”
Get full text

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia by Masternak, Marta, Puła, Bartosz, Knap, Joanna, Waszczuk-Gajda, Anna, Drozd-Sokołowska, Joanna, Wdowiak, Kamil, Grosicki, Sebastian, Kozłowska, Izabela, Kaźmierczak, Marta, Łabędź, Anna, Szukalski, Łukasz, Wiśniewski, Kamil, Subocz, Edyta, Hałka, Janusz, Szymczyk, Agnieszka, Hus, Marek, Jamroziak, Krzysztof, Giannopoulos, Krzysztof

“…Mean platelet volume (MPV) is a readily accessible and commonly tested hematological indicator. Recent studies revealed a significant impact of MPV on the…”
Get full text

The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study by Pérez Encinas, Manuel M., Sobas, Marta, Gómez‐Casares, María Teresa, Abuin Blanco, Aitor, Noya Pereira, María Soledad, Raya, José María, Andrade‐Campos, Marcio M., Álvarez Larrán, Alberto, Lewandowski, Krzysztof, Łukasz, Szukalski, Hernández Boluda, Juan Carlos, Ferrer‐Marín, Francisca, Fox, María Laura, Gołos, Aleksandra, Gasior Kabat, Mercedes, Magro Mazo, Elena, Czyż, Anna, Martín Martín, Alejandro, Bellosillo Paricio, Beatriz, Quinteiro García, Celsa, González Martín, Jesús María, Stuckey, Ruth

“…Objectives In patients with essential thrombocythemia (ET), after the JAK2V617F driver mutation, mutations in CALR are common (classified as type 1, 52‐bp…”
Get full text

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma by Kubicki, Tadeusz, Dytfeld, Dominik, Barnidge, David, Sakrikar, Dhananjay, Przybyłowicz-Chalecka, Anna, Jamroziak, Krzysztof, Robak, Paweł, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Wróbel, Tomasz, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan Maciej, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Jiang, Ken, Cooperrider, Jennifer H., Jakubowiak, Andrzej J., Derman, Benjamin A.

“…•MS provides significant prognostic information in the maintenance setting and complements BM MRD in multiple myeloma.•Without the aid of a baseline serum…”
Get full text

Pneumonia in patients with chronic lymphocytic leukemia treated with venetoclax‐based regimens: A real‐world analysis of Polish Adult Leukemia Group (PALG) by Kalicińska, Elżbieta, Jablonowska‐Babij, Paula, Morawska, Marta, Iskierka‐Jażdżewska, Elżbieta, Drozd‐Sokolowska, Joanna, Paszkiewicz‐Kozik, Ewa, Szukalski, Łukasz, Strzała, Judyta, Gosik, Urszula, Dębski, Jakub, Andrasiak, Iga, Skotny, Anna, Jamroziak, Krzysztof, Wrobel, Tomasz

“…Abstract Background Patients with chronic lymphocytic leukemia (CLL) are susceptible to infections that can affect their clinical outcomes. Aims To assess: (1)…”
Get full text

Hematological Malignancies in the Polish Population: What are the Predictors of Outcome in Patients Admitted to Intensive Care Unit? by Kalicińska, Elżbieta, Kuszczak, Bartłomiej, Dębski, Jakub, Szukalski, Łukasz, Czyż, Jarosław, Wątek, Marzena, Lech-Marańda, Ewa, Strzała, Judyta, Zaucha, Jan Maciej, Rybka, Justyna, Wróbel, Tomasz

Get full text

The Prognostic Impact of t(14;16) in Multiple Myeloma: A Multicenter Retrospective Study of 213 Patients. Is It Time to Revise the Revised ISS? by Jurczyszyn, Artur, Goldman-Mazur, Sarah, Castillo, Jorge J., Waszczuk-Gajda, Anna, Grząśko, Norbert, Radocha, Jakub, Bittrich, Max, Gozzetti, Alessandro, Usnarska-Zubkiewicz, Lidia, Hus, Iwona, Yee, Andrew J, Jayabalan, David S, Niesvizky, Ruben, Kelman, Julia, Coriu, Daniel, Rosinol Dachs, Laura, Szukalski, Łukasz, Dávila, Julio, Gonzalez De La Calle, Veronica, Jamroziak, Krzysztof, Avivi, Irit, Cohen, Yael C, Suska, Anna, Chappell, Aimee, Madduri, Deepu, Chhabra, Saurabh, Kleman, Ariel, Hari, Parameswaran, Robak, Paweł, Gentile, Massimo, Kozłowska, Izabela, Goldberg, Stuart L., Vesole, David H

“…Introduction One of the strongest predictors of outcome in multiple myeloma (MM) patients are the intrinsic genetic abnormalities in the malignant plasma…”
Get full text